PHARMACO

PHARMACO has been active since 1989 and the Belgian State Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €193,513 and a net result of €31. Equity remains stable across the filed fiscal years (±1.2% per year). Its solvency ranks better than 54% of 375 sector peers (fiscal year 2026). The computed 12-month bankruptcy probability is 0.1% (very low).